Click here to modify your search at PubMed.
- A systematic review of the real-world effectiveness and economic and humanistic outcomes of selected oral antipsychotics among patients with schizophrenia in the United States: Updating the evidence and gaps. J Manag Care Spec Pharm. 2024 PMID: 38308625 (DARE summary if available); Cite
- Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysis. World Psychiatry. 2023 PMID: 37159349 (DARE summary if available); Cite
- Comparison of antipsychotic dose equivalents for acute bipolar mania and schizophrenia. BMJ Ment Health. 2023 PMID: 36789916 (DARE summary if available); Cite
- Onset of Action of Selected Second-Generation Antipsychotics (Pines)-A Systematic Review and Meta-Analyses. Biomedicines. 2022 PMID: 36672589 (DARE summary if available); Cite
- A Meta-Analysis of Antipsychotic-Induced Hypo- and Hyperprolactinemia in Children and Adolescents. J Child Adolesc Psychopharmacol. 2022 PMID: 36074098 (DARE summary if available); Cite
- Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review. Front Psychiatry. 2021 PMID: 34975600 (DARE summary if available); Cite
- New Antipsychotic Medications in the Last Decade. Curr Psychiatry Rep. 2021 PMID: 34843030 (DARE summary if available); Cite
- Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in Japan. J Psychiatr Res. 2021 PMID: 33964682 (DARE summary if available); Cite
- Transdermal Asenapine in Schizophrenia: A Systematic Review. Patient Prefer Adherence. 2020 PMID: 32943849 (DARE summary if available); Cite
- Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan. Pharmacopsychiatry. 2020 PMID: 32000271 (DARE summary if available); Cite
- Lurasidone compared to other atypical antipsychotic monotherapies for adolescent schizophrenia: a systematic literature review and network meta-analysis. Eur Child Adolesc Psychiatry. 2020 PMID: 31758359 (DARE summary if available); Cite
- Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review. Prim Care Companion CNS Disord. 2019 PMID: 31237432 (DARE summary if available); Cite
- Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis. CNS Drugs. 2019 PMID: 31065941 (DARE summary if available); Cite
- Acute Antipsychotic Treatment of Children and Adolescents With Schizophrenia-Spectrum Disorders: A Systematic Review and Network Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2017 PMID: 28219485 (DARE summary if available); Cite
- Asenapine for the Treatment of Psychotic Disorders. Can J Psychiatry. 2017 PMID: 27481921 (DARE summary if available); Cite
- Asenapine versus placebo for schizophrenia. Cochrane Database Syst Rev. 2015 PMID: 26599405 (DARE summary if available); Cite
- Adverse events and treatment failure leading to discontinuation of recently approved antipsychotic drugs in schizophrenia: A network meta-analysis. Schizophr Res. 2015 PMID: 26516102 (DARE summary if available); Cite
- Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. Pharmacoeconomics. 2015 PMID: 25963579 (DARE summary if available); Cite
- The quality of reporting of phase II and III trials for new antipsychotics: a systematic review. Psychol Med. 2015 PMID: 25065545 (DARE summary if available); Cite
- A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach. CNS Drugs. 2013 PMID: 24062193 (DARE summary if available); Cite
- Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis. CNS Drugs. 2012 PMID: 22900950 (DARE summary if available); Cite
- Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. J Manag Care Pharm. 2012 PMID: 22784311 (DARE summary if available); Cite
- A systematic review of meta-analyses of the efficacy of oral atypical antipsychotics for the treatment of adult patients with schizophrenia. Expert Opin Pharmacother. 2012 PMID: 21999805 (DARE summary if available); Cite
|
You found 50 or more articles.
Thursday, 28 Mar 2024 04:14:12 at SUMSearch
|